OAR 836-200-0515: Threshold for Reporting Drug Price Increase
Edition: Current OARD snapshotEffective: 2026-02-13Last verified: 2026-09-07
(1) No later than July 1, 2019, a reporting manufacturer must report the information described in OAR 836-200-0530(2) to the department regarding each prescription drug for which: (a) The price at any point in 2018 was $100 or more for a one-month supply; and (b) There was a net yearly increase of 10 percent or more in the price of the prescription drug described in subsection (a) of this section during 2018. (2) Beginning February 16, 2024, no later than March 15 annually, a reporting manufacturer may voluntarily report to the department the information described in OAR 836-200-0530(2) regarding each prescription drug for which: (a) The price at any point during the previous year was $100 or more for a one-month supply; and (b) There was a net yearly increase of 10 percent or more in the price of the prescription drug described in subsection (a) of this section over the course of the previous calendar year.
Official history and status
Statutory/Other Authority: ORS 646A.689
Statutes/Other Implemented: ORS 646A.689
History: ID 1-2026, temporary amend filed 02/12/2026, effective 02/13/2026 through 08/11/2026 ID 2-2025, amend filed 03/26/2025, effective 04/01/2025 ID 2-2019, adopt filed 02/26/2019, effective 03/01/2019
This rule cites
- OAR 836-200-0530 — resolved
Cited by
- OAR 836-200-0505: Definitions
- OAR 836-200-0530: Form and Manner Requirements for Drug Pricing Reporting
- OAR 836-200-0532: Prescription Drug Reporting – Patient Assistance Programs
- OAR 836-200-0535: Additional Information Requests
- OAR 836-200-0540: Information Claimed to be Trade Secret
- OAR 836-200-0555: Assessments Against Prescription Drug Manufacturers for 2023 and prior
Official source: https://secure.sos.state.or.us/oard/